These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6758690)

  • 21. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of prototrophic natural variants of Candida albicans.
    Goshorn AK; Scherer S
    Genetics; 1989 Dec; 123(4):667-73. PubMed ID: 2575557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of action of 5-fluorocytosine and mechanisms of resistance.
    Polak A; Scholer HJ
    Chemotherapy; 1975; 21(3-4):113-30. PubMed ID: 1098864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
    Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
    Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
    Brinkmann F
    Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action mechanism of 5-fluorocytosine. IV. Morphological observation and development of the resistant cells].
    Arai T; Mikami Y; Kawada T; Masuda K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):257. PubMed ID: 765563
    [No Abstract]   [Full Text] [Related]  

  • 28. Observations on 5-fluorocytosine and Candida albicans.
    Davies RR; Savage MA
    Sabouraudia; 1974 Nov; 12(3):302-8. PubMed ID: 4610822
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine.
    Auger P; Dumas C; Joly J
    J Infect Dis; 1979 May; 139(5):590-4. PubMed ID: 374653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of 5-fluorocytosine on the temperature profile of Candida albicans.
    Lemos-Carolino M; Madeira-Lopes A
    Sabouraudia; 1984; 22(4):351-4. PubMed ID: 6390737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 33. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S; Doluca Dereli M
    Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphological changes in yeasts as a result of the action of 5-fluorocytosine.
    Arai T; Mikami Y; Yokoyama K; Kawata T; Masuda K
    Antimicrob Agents Chemother; 1977 Aug; 12(2):255-60. PubMed ID: 332075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.